Reversal of oxidative stress by histamine H 3 receptor-ligands in experimental models of schizophrenia

Arzneimittel-Forschung/Drug Research

Volumn 62, Issue 5, 2012, Pages 222-229

  Mahmood, D ^a   Khanam, R ^a   Pillai, K K ^a   Akhtar, M ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

amphetamine; histamine H 3 antagonists; MK 801; oxidative stress; schizophrenia

Indexed keywords

AMPHETAMINE; APOMORPHINE; CATALASE; CIPROXIFAN; CLOBENPROPIT; DIZOCILPINE; GLUTATHIONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BEHAVIOR; CATALEPSY; CLIMBING; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE CONTROL; DRUG EFFECT; DRUG EFFICACY; MOTOR DYSFUNCTION; NEGATIVE SYNDROME; NONHUMAN; OXIDATIVE STRESS; PREMEDICATION; RAT; SCHIZOPHRENIA;

AMPHETAMINE; ANIMALS; ANTIOXIDANTS; ANTIPSYCHOTIC AGENTS; APOMORPHINE; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CATALASE; CATALEPSY; CENTRAL NERVOUS SYSTEM STIMULANTS; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GLUTATHIONE; HALOPERIDOL; HISTAMINE H3 ANTAGONISTS; MALE; MICE; MOTOR ACTIVITY; OXIDATIVE STRESS; RATS; SCHIZOPHRENIA; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84861635148     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1301326     Document Type: Article

References (70)

1. Kuloglu M, Ustundag B, Atmaca M et al. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Func: 2002; 20 171 175
2. Ranjekar P K, Hinge A, Hegde M et al. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiat Res: 2003; 121 109 122 (Pubitemid 37500981)
3. Ozcan M E, Gulec M, Ozerol E et al. Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacology: 2004; 19 89 95 (Pubitemid 38316767)
4. Lohr J B. Oxygen Radicals and Neuropsychiatric Illnesses. Arch Gen Psych: 1991; 48 1097 1106
5. Mahadik S P, Scheffer R E. Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglan Leuk Essen Fatty Acids: 1996; 55 45 54 (Pubitemid 26321117)
6. Ogawa N. Free radicals and neural cell damage. Rinsho Shinkeigaku: 1994; 34 1266 1288
7. Bandopadhyay D, Das D, Banarjee R K. Reactive oxygen species: Oxidative damage and pathogenesis. Cur Sci: 1999; 77 658 666 (Pubitemid 129558409)
8. Floyd R A. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med: 1999; 222 236 245 (Pubitemid 129708638)
9. Sies H. Oxidative stress: From basic research to clinical application. Am J Med: 1991; 91 31S 38S
10. Stohs S J. The role of free radicals in toxicity and disease. J Basic Physio Pharmacol: 1995; 6 1097 1106
11. Yao J K, Reddy R D, van Kammen D P. Oxidative damage and schizophrenia: An overview of the evidence and its therapeutic implications. CNS Drugs: 2001; 15 287 310 (Pubitemid 32337052)
12. Mahadik S P, Mukherjee S. Free radical pathology and antioxidant defense in schizophrenia: A review. Schizophr Res: 1996; 19 1 17 (Pubitemid 26133208)
13. Finklestein E, Rosen G M, Rauckman E J. Spin trapping: Kinetics of the reaction of superoxide and hydroxyl radicals with nitrones. J Am Chem Soc: 1980; 102 4994 4999
14. Cheeseman K H, Slater T F. An introduction to free radical biochemistry. Br Med Bull: 1993; 49 481 493 (Pubitemid 23243824)
15. McCord J M. The evolution of free radical and oxidative stress. Am J Med: 2000; 108 652 659 (Pubitemid 30336605)
16. 3) of histamine receptor. Nature: 1983; 302 832 837 (Pubitemid 13125123)
17. 3 receptors. Nature: 1987; 327 117 123 (Pubitemid 17062756)
18. 2 receptor stimulation in the rat striatum. Eur J Pharmacol: 2004; 484 167 173 (Pubitemid 38117207)
19. 3 receptor antagonists reduce superoxide generation and lipid peroxidation in rat brain homogenates. J Pharm Pharmacol: 2005; 57 781 785 (Pubitemid 40694887)
20. Akhtar M, Pillai K K, Vohora D. Effect of thioperamide on modified forced swimming test-induced oxidative stress in mice. Basic Clin Pharmacol Toxicol: 2005; 97 218 221 (Pubitemid 41433694)
21. Akhtar M, Pillai K K, Vohora D. Effect of thioperamide on oxidative stress markers in middle cerebral artery occlusion model in rats. Hum Exp Toxicol: 2008; 27 761 767
22. Marchese G, Casu G, Casti P et al. Evaluation of amphetamine induced hyperlocomotion and catalepsy following long acting risperidone administration in rats. Eur J Pharmacol: 2009; 620 36 41
23. 3-receptor inverse agonists studied with BF2.649. Biochem Pharmacol: 2007; 47 1215 1224 (Pubitemid 46420689)
24. Castall B, Naylor R J, Nohria V. Climbing behavior induced by apomorphine in ic: A potential de for the detection of neuroleptic activity. Eur J Pharmacol: 1978; 50 39 50 (Pubitemid 9202912)
25. 3-receptor antagonist in mice. Fundam Clin Pharmacol: 2006; 20 04 373 378 (Pubitemid 44034327)
26. 3 receptor antagonist on neuroleptic induced catalepsy in mice. Neuropharmacol: 1995; 34 97 99
27. Ohkawa H, Oishi N, Yagi K. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem: 1979; 95 351 358 (Pubitemid 9194347)
28. Ellman G L. Tissue sulfhydryl groups. Arch Biochem Biophys: 1957; 82 70 77
29. Claiborne A. Catalase activities. In: Greenwald R A. (ed.). CRC handbook of methods in oxygen radical research. Boca Raton CRC Press: 1985; 283 284
30. Marklund S, Marklind G. Involvement of superoxide anion radical in the auto oxidation of pyrogallol and a convenient assay for superoxidedismutase. Eur J Biochem: 1974; 47 469 474
31. Mohandas J, Marshal J J, Diggin G G et al. Low activities of glutathione related enzymes a factor in the genesis of urinary bladder cancer. Cancer Res: 1984; 44 5086 5091 (Pubitemid 15204468)
32. Habiq W H, Prast M J, Jakoby W B. Glutathione S-transferase. J Biol Chem: 1974; 249 7130 7139
33. Carlberg I, Mannervik B. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem: 1975; 259 5475 5480
34. Coyle J T, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science: 1993; 262 689 695 (Pubitemid 23350687)
35. Fendri C, Mechri A, Khiari G et al. Oxidative stress involvement in schizophrenia pathophysiology: A review. Encephale: 2006; 32 244 252 (Pubitemid 43670234)
36. Marchbanks R M, Ryan M, Day I N et al. A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress. Schizophr Res: 2003; 65 33 38 (Pubitemid 37410401)
37. Munakata K, Iwamoto K, Bundo M et al. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol Psych: 2005; 57 525 532 (Pubitemid 40311988)
38. Vilner B J, DeCosta B R, Bowen W D. Cytotoxic effects of sigma ligands: sigma receptor mediated alteration in cellular morphology and viability. J Neurosci: 1995; 15 117 134
39. Rollema H, Skolnik M, Dengelbronner J et al. MPP(+)-like neurotoxicity of pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies. J Pharmacol Exp Ther: 1994; 268 380 387 (Pubitemid 24039112)
40. Yokoyama H, Kasai N, Ueda Y et al. In vivo analysis of hydrogen peroxide and lipid radicals in the striatum of rats under long-term administration of a neuroleptic. Free Radic Biol Med: 1998; 26 1056 1060 (Pubitemid 28186247)
41. Creese I, Burt D, Snyder S H. Dopamine receptor binding and pharmacological potencies of antischizophrenic drugs. Science: 1976; 192 481 483
42. Westerink BH C, Vries J B. On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence of mediation by auto receptors localized on nerve terminals. Neurosci Lett: 1989; 99 197 202 (Pubitemid 19098462)
43. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem: 1992; 59 1609 1623
44. Sit S Y. Dopamine agonists in the treatment of Parkinson's disease - past, present and future. Curr Pharm Des: 2000; 6 1211 1248 (Pubitemid 30604734)
45. El-Bacha R S, Daval J, Koziel V et al. Toxic effects of apomorphine on rat cultured neurones and glial C6 cells and protection with antioxidants. Biochem Pharmacol: 2001; 66 73 85 (Pubitemid 32013056)
46. Ubeda A, Montesinos C, Paya M et al. Iron reducing and free radical scavenging properties of apomorphine and some related benzylisoquinolines. Free Radic Biol Med: 1993; 15 159 167 (Pubitemid 23218818)
47. Bindolli A, Rigobello M P, Deeble D J. Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radic Biol Med: 1992; 13 391 405
48. Picada J N, Roesler R, Henriques JA P. Genotoxic, neurotoxic and neuroprotective activities of apomorphine and its oxidized derivative 8-oxo-apomorphine. Br J Med Biol Res: 2005; 38 477 486 (Pubitemid 40691997)
49. Burrows K B, Gudelsky G, Yamamoto B K. Rapid and transient inhibition of mitochondrial function following methamphetamine or 3, 4- methylenedioxymethamphetamine administration. Eur J Pharmacol: 2000; 398 11 18 (Pubitemid 30336672)
50. Sonsalla P K, Nicklas W J, Heikkila R E. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science: 1989; 243 398 400 (Pubitemid 19047519)
51. Berman S B, Hastings T G. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J Neurochem: 1999; 73 1127 1137 (Pubitemid 29395471)
52. Willis C L, Ray D E. Antioxidants attenuate MK-801-induced cortical neurotoxicity in the rat. Neuro Toxicol: 2007; 28 161 167 (Pubitemid 46187274)
53. Ozyurt B, Sarsilmaz M, Akpolat N et al. The protective effects of omega-3 fatty acids against MK-801-induced l neurotoxicity in the prefrontal cortex of rat. Neurochem Int: 2007; 50 196 202 (Pubitemid 44879676)
54. Zuo D-Y, Wu Y-L, Yao W-X et al. Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis. Pharm Biochem Behav: 2007; 86 1 7 (Pubitemid 46274964)
55. Ozyurt B, Ozyurt H, Akpolat N et al. Oxidative stress in prefrontal cortex of rat exposed to MK801 and protective effects of CAPE. Progr Neuro-psychopharmacol Biol Psych: 2007; 31 832 838 (Pubitemid 46660297)
56. Mates J M. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology: 2000; 153 83 104
57. Zhang X, Boulton A A, Zuo D M et al. MK-801 induces apoptotic neuronal death in the rat retrosplenial cortex: prevention by cycloheximide and R ()-2-hexyl-N-methylpropargylamine. J Neurosci Res: 1996; 46 82 89 (Pubitemid 26330581)
58. Bueno A, De Olmos S, Heimer L et al. NMDA-antagonist MK-801-induced neuronal degeneration in Wistar rat brain detected by the Amino-Cupric-Silver method. Exp Toxicol Pathol: 2003; 54 319 334 (Pubitemid 36362238)
59. Halliwell B. Free radicals, antioxidants and human diseases: Curiosity, cause or consequence? Lancet: 1994; 344 721 724
60. Frei B. Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am J Med: 1994; 97 5S 13S
61. Benedicta D, Vivian D. Oxidative injury and antioxidant vitamins E and C in Schizophrenia. Ind J Clin Biochem: 2003; 18 87 90
62. Ansari K U. Free Radical induced diseases. JIMA: 1996; 94 238 239
63. Polydoro M, Schroder N, Lima MN M et al. Haloperidol and clozapine induced oxidative stress. Pharmacol Biochem Behav: 2004; 78 751 756 (Pubitemid 39037735)
64. Moreira FC J, Dal-Pizzol F, Bonatto F et al. Oxidative damage in brains of mice treated with apomorphine and its oxidized product. Brain Res: 2003; 246 251 (Pubitemid 37415107)
65. Frey N B, Valvassori S S, Gomes M K et al. Increased oxidative stress in sub-mitochondrial particles after chronic amphetamine exposure. Brain Res: 2006; 1097 224 229 (Pubitemid 44041287)
66. Mates J M, Perez-Gomez C, Nunez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem: 1999; 32 595 603 (Pubitemid 30039087)
67. 3 receptor as a novel therapeutic target for cognitive and sleep disorders. Trends Pharmacol Sci: 2004; 25 618 625 (Pubitemid 39458167)
68. Yanai K, Tashiro M. The physiological and pathophysiological roles of neuronal histamine: An insight from human positron emission tomography studies. Pharmacol Ther: 2007; 113 1 15 (Pubitemid 44969926)
69. 3 receptor: an attractive target for the treatment of cognitive disorders. Br J Pharmacol: 2008; 154 1161 1181
70. 3 receptor as a therapeutic drug target for CNS disorders. DDT: 2009; 14 509 515